Prospects for a novel ultrashort pulsed laser technology for pathogen inactivation

Shaw Wei D Tsen, Tzyy Choou Wu, Juliann G. Kiang, Kong Thon Tsen

Research output: Contribution to journalArticle

Abstract

The threat of emerging pathogens and microbial drug resistance has spurred tremendous efforts to develop new and more effective antimicrobial strategies. Recently, a novel ultrashort pulsed (USP) laser technology has been developed that enables efficient and chemical-free inactivation of a wide spectrum of viral and bacterial pathogens. Such a technology circumvents the need to introduce potentially toxic chemicals and could permit safe and environmentally friendly pathogen reduction, with a multitude of possible applications including the sterilization of pharmaceuticals and blood products, and the generation of attenuated or inactivated vaccines.

Original languageEnglish (US)
Article number62
JournalJournal of Biomedical Science
Volume19
Issue number1
DOIs
StatePublished - 2012

Fingerprint

Pathogens
Pulsed lasers
Lasers
Technology
Attenuated Vaccines
Inactivated Vaccines
Poisons
Microbial Drug Resistance
Pharmaceutical Preparations
Blood

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Molecular Biology
  • Cell Biology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism
  • Pharmacology (medical)

Cite this

Prospects for a novel ultrashort pulsed laser technology for pathogen inactivation. / Tsen, Shaw Wei D; Wu, Tzyy Choou; Kiang, Juliann G.; Tsen, Kong Thon.

In: Journal of Biomedical Science, Vol. 19, No. 1, 62, 2012.

Research output: Contribution to journalArticle

Tsen, Shaw Wei D ; Wu, Tzyy Choou ; Kiang, Juliann G. ; Tsen, Kong Thon. / Prospects for a novel ultrashort pulsed laser technology for pathogen inactivation. In: Journal of Biomedical Science. 2012 ; Vol. 19, No. 1.
@article{b724dd59ac9841aa97a71a5e4efc9370,
title = "Prospects for a novel ultrashort pulsed laser technology for pathogen inactivation",
abstract = "The threat of emerging pathogens and microbial drug resistance has spurred tremendous efforts to develop new and more effective antimicrobial strategies. Recently, a novel ultrashort pulsed (USP) laser technology has been developed that enables efficient and chemical-free inactivation of a wide spectrum of viral and bacterial pathogens. Such a technology circumvents the need to introduce potentially toxic chemicals and could permit safe and environmentally friendly pathogen reduction, with a multitude of possible applications including the sterilization of pharmaceuticals and blood products, and the generation of attenuated or inactivated vaccines.",
author = "Tsen, {Shaw Wei D} and Wu, {Tzyy Choou} and Kiang, {Juliann G.} and Tsen, {Kong Thon}",
year = "2012",
doi = "10.1186/1423-0127-19-62",
language = "English (US)",
volume = "19",
journal = "Journal of Biomedical Science",
issn = "1021-7770",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Prospects for a novel ultrashort pulsed laser technology for pathogen inactivation

AU - Tsen, Shaw Wei D

AU - Wu, Tzyy Choou

AU - Kiang, Juliann G.

AU - Tsen, Kong Thon

PY - 2012

Y1 - 2012

N2 - The threat of emerging pathogens and microbial drug resistance has spurred tremendous efforts to develop new and more effective antimicrobial strategies. Recently, a novel ultrashort pulsed (USP) laser technology has been developed that enables efficient and chemical-free inactivation of a wide spectrum of viral and bacterial pathogens. Such a technology circumvents the need to introduce potentially toxic chemicals and could permit safe and environmentally friendly pathogen reduction, with a multitude of possible applications including the sterilization of pharmaceuticals and blood products, and the generation of attenuated or inactivated vaccines.

AB - The threat of emerging pathogens and microbial drug resistance has spurred tremendous efforts to develop new and more effective antimicrobial strategies. Recently, a novel ultrashort pulsed (USP) laser technology has been developed that enables efficient and chemical-free inactivation of a wide spectrum of viral and bacterial pathogens. Such a technology circumvents the need to introduce potentially toxic chemicals and could permit safe and environmentally friendly pathogen reduction, with a multitude of possible applications including the sterilization of pharmaceuticals and blood products, and the generation of attenuated or inactivated vaccines.

UR - http://www.scopus.com/inward/record.url?scp=84863439050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863439050&partnerID=8YFLogxK

U2 - 10.1186/1423-0127-19-62

DO - 10.1186/1423-0127-19-62

M3 - Article

C2 - 22768792

AN - SCOPUS:84863439050

VL - 19

JO - Journal of Biomedical Science

JF - Journal of Biomedical Science

SN - 1021-7770

IS - 1

M1 - 62

ER -